A venture arm of a hospital system started investing in early-stage companies through their venture team that was founded in 2022. The team focuses primarily in digital health companies seeking Pre-Seed to Series A investment rounds. The team’s mandate is solving clinical or operational challenges through strategic partnerships that align directly with the hospital system’s core values. The firm does not lead capital investments but will integrate strategic partners into the hospital system through pilot programs before eventually investing in equity. The firm’s equity investments are typically between USD $500k – $2M, but the fund can invest more. The fund is looking to invest in 4-6 companies yearly.
The firm invests primarily within digital health companies that are ready to be integrated within the hospital system; the fund is opportunistic to indication and platform within their digital health investments. The firm may also make investments into diagnostics or medical device companies. For medical device investments, the fund prefers to invest in companies that are nearing clinical completion, or already on market. The fund does not invest in therapeutics.
The fund does not have any strict company or management team requirements. Although an experienced management team is preferred, the fund is willing to invest in any company that is willing to provide tag-along rights. The fund invests within North America, Europe, Australia, and South America and is open to global opportunities that are capable of being integrated into the hospital system. The fund does not typically lead investments.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment